A, B., V, J., Y, D., J, D., E, L., A, J., . . . B, T. (2026). Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome. Rheumatology (Oxford, England), 65(5), . https://doi.org/10.1093/rheumatology/keag194
Chicago Style (17th ed.) CitationA, Betrains, et al. "Spectrum and Significance of 18F-FDG-PET/CT Abnormalities in VEXAS Syndrome." Rheumatology (Oxford, England) 65, no. 5 (2026). https://doi.org/10.1093/rheumatology/keag194.
MLA (9th ed.) CitationA, Betrains, et al. "Spectrum and Significance of 18F-FDG-PET/CT Abnormalities in VEXAS Syndrome." Rheumatology (Oxford, England), vol. 65, no. 5, 2026, https://doi.org/10.1093/rheumatology/keag194.
Warning: These citations may not always be 100% accurate.